ESC

CONGRESS
2021
THE DIGITAL EXPERIENCE

27 - 30 August

PROGRAMME AT A GLANCE as of 21 July 2021

www.escardio.org/ESC2021
#ESCCongress
FRIDAY, 27 AUGUST All times in the programme are Central European Summer Time (CEST).

> LIVE ABSTRACT PRESENTATIONS & DISCUSSIONS > CHANNEL PROGRAMME

07:15 Novel approaches to catheter ablation Channel 1 - COVID-19 Channel 2 - Latest Science Channel 3 - Arrhythmias
and Device Therapy
07:15 Novel insights in non-coding RNA functions
08:00 The collateral damage of COVID-19 08:00 The Future of Cardiology - 08:00 Choosing wisely : ablation or medi-
on CVD Joint leadership session ACC/AHA/ cation for rhythm control in atrial
07:15 Highlights from the Young: artificial intelligence in imaging
WHF fibrillation ?
09:00 Navigating obesity treatment for
07:15 Emerging concepts in the evaluation of coronary artery disease prevention of CVD - Organised 09:30 Cardiology at an inflection point : 09:30 Preventing sudden death: alternatives
by International Medical Press, where will the future take us ? to transvenous defibrillators
07:15 Congenital heart disease: why is it always a challenge to diagnose and treat ? supported by an educational grant - Joint with the International Society
from Novo Nordisk A/S for Cardiovascular Translational 10:30 Late Breaking Science in Arrhythmias
07:15 SARS-CoV-2 in pulmonary circulation: does it do as much harm as in the Research (ISCTR) 11:30 Neuromodulation for the management
alveoli ? 09:30 Influenza, COVID-19, vaccinations, and
cardiovascular risk - Joint with the 10:30 Late Breaking Trials in ACS of patients with HFrEF : the present
07:15 Consequences of COVID-19 in heart failure : one year on Inter-American Society of Cardiology and the future - Sponsored by Charité
(IASC) 11:30 Future direction of remote cardiac Universitätsmedizin Berlin
07:15 Biomarkers to improve prognostication in heart failure: what's new ? monitoring - Sponsored by
10:30 COVID-19: who is at risk ? BIOTRONIK 12:00 Great Debate: ICD indications for
primary prevention in patients with
07:15 Recent advances in diagnosis/treatment of hypertension 11:30 From Trials to Clinical Practice : Hy- 12:00 The SCORE2 and SCORE2-Op risk dilated cardiomyopathy – time for a
pertension Management in Real-World algorithms to estimate ASCVD risk change ?
07:15 Coronary revascularisation focusing on outcomes Settings - Sponsored by Menarini
Group 13:00 Detect, triage and treat atrial 13:00 Improving long-term outcomes in

FRIDAY, 27 AUGUST
07:15 Psychosocial aspects for cardiovascular risk fibrillation and heart failure - Pulmonary Arterial Hypertension :
12:00 Long COVID: does it matter ? Sponsored by Medtronic Time matters ! - Sponsored by
07:15 Highlights from the Young in emerging cardiovascular interventions Janssen
13:00 Influenza and cardiovascular outco-
mes: protection beyond flu during
the time of Covid-19 - Sponsored by
Sanofi Pasteur

Channel 4 - Basic Science Channel 5 - Coronary Artery Channel 6 - Heart Failure

Disease - Acute Cardiac Care
08:00 Cardiovascular consequences 08:00 Guidelines in Practice: management of 08:00 Atrial fibrillation in heart failure :
post-COVID: bench to bedside the patient with asymptomatic chronic pharmacological or ablation therapy ?
coronary syndrome
09:30 Dietary interventions for optimised 09:30 How should I treat my patient with
cardiovascular health 09:30 Sudden cardiac death : can we move acute heart failure ?
from prediction to prevention ?
11:30 Tricuspid valve therapy pathway - 10:30 Late Breaking Science in Heart Failure
Sponsored by GE Healthcare 10:30 Fighting sudden cardiac death the
digital way 11:30 Transforming Outcomes for Patients
12:00 Immunotherapy for cardiovascular with hATTR Amyloidosis - Sponsored
disease 11:30 Home screening for stroke prevention : by Alnylam Pharmaceuticals
a practical assessment - Sponsored by
13:00 Exploring the latest evidence of OMRON Healthcare Europe B.V. 12:00 Great Debate: modern medical
cardiovascular benefits with gluca- therapy makes primary prevention
gon-like peptide 1 receptor agonists - 12:00 Great Debate: is revascularisation ICDs obsolete in patients with
Sponsored by Novo Nordisk A/S primarily intended for chronic HFrEF
coronary syndrome patients with
symptoms refractory to medical 13:00 Redefining intensive LDL-c manage-
therapy ? ment in high risk patients : The case
for combination therapy - Sponsored
13:00 A Multi-Specialty View of the Latest by PACE-CME
Data from VERTIS CV and How it
Informs Clinical Treatment Decisions
for Patients - Sponsored by Merck
Sharp & Dohme

2
FRIDAY, 27 AUGUST All times in the programme are Central European Summer Time (CEST).

> CHANNEL PROGRAMME

Channel 7 - Cardiovascular Imaging Channel 8 - Interventional Cardiology & Channel 9 - Preventive Cardiology, Channel 10 - Valvular, Myocardial, Pericardial, Channel 11 - General Cardiology
CV Surgery, Stroke, PAD, Aortic Disease Special Populations Pulmonary, Congenital Heart Disease
08:00 Meet the Experts : 4D flow cardiac 08:00 Guidelines in Practice : antithrombotic 08:00 Lipoprotein(a) : an emerging lipid risk 08:00 How should I treat a patient with 08:00 Meet the Experts: cardiomyopathies
magnetic resonance in clinical therapy in atrial fibrillation and acute factor severe aortic stenosis and coronary and sudden cardiac death
practice myocardial infarction artery disease at low surgical risk ?
09:30 What's next to reduce cardiovascular 09:30 Meet the Experts : thoracic aortic
09:30 Multimodality cardiac imaging to solve 09:30 A practical approach to the patient risk ? 09:30 Decision dilemmas in venous throm- diseases – a clinical appraisal for
challenging diagnostic questions with claudication boembolism cardiology practice
10:30 Telerehabilitation in cardiology : is it
10:30 What is the role of cardiac magnetic 10:30 Aberrant coronary arteries : surgical the future ? 10:30 New directions in pulmonary vascular 10:30 When and how to allow sport
resonance for risk stratification in treatment indications and techniques intervention activities: a general cardiologist's
cardiomyopathies ? - Joint with the European Association 12:00 Great Debate: controversy – do perspective
for Cardio-Thoracic Surgery (EACTS) patients benefit from omega-3 fatty 12:00 TAVI in 2021: state of the art
12:00 Echocardiography: doing it right in acids ? 12:00 Are we following the 2018 ESC/ESH
2021 and beyond 12:00 Great Debate: transcatheter mitral Guidelines on Management of Arterial
valve repair/replacement for Hypertension in Elderly Patients ?
secondary mitral regurgitation –
routine or niche ?

FRIDAY, 27 AUGUST
Channel 12 - Awards Channel 13 - Core Cardiology Channel 14 - Cardiology Toolbox Channel 15 - International
and Named Lectures Joint Sessions
08:00 Young Investigator Awards Session in 08:00 Essentials in Imaging – 1 : Optimal 08:00 The practicalities of drug treatment in 08:00 Cardiology and Cancer - Joint with
Population Sciences use of imaging techniques to address heart failure the European Cancer Organisation
some of the most challenging ques- (ECO)
09:30 ESC Geoffrey Rose Lecture in tions in cardiology 09:30 How to handle bleeding in patients on
Population Sciences and Florence oral anticoagulation 09:30 Rethinking therapeutic and diagnostic
Nightingale Lecture in Nurse-Led 09:30 Essentials in Valvular Heart Disease – strategies for chronic coronary
Research 1: Aortic and mitral valve disease 10:30 Echocardiographic quantification syndromes : European and Japanese
of mitral, aortic and tricuspid perspectives after the ISCHEMIA trial
10:30 Nursing and Allied Professions 10:30 Essentials in Prevention - 1 : Cardio- regurgitation : a cookbook approach - Joint with the Japanese Circulation
Investigator Awards vascular Epidemiology and Primary Society (JCS)
Prevention 12:00 Managing patients with PFO : practical
advice 10:30 Tailored approach for late presenters
12:00 Essentials in the Cardiology Clinic - 1 : with congenital heart disease - Joint
Venous, Peripheral Artery and Aortic with the Pan Arab Congenital Heart
Disease Disease Association (PACHDA)
12:00 Update : arrhythmogenic
cardiomyopathy and long QT
syndrome - Joint with the South
African Heart Association (SAHA)

3
FRIDAY, 27 AUGUST All times in the programme are Central European Summer Time (CEST).

> PRIME
CHANNEL
TIME
BYPROGRAMME
TOPIC PROGRAMME

14:00 Inaugural Session

14:30 Hot Line - Dal-GenE

15:00 A Changing Paradigm: Defining the Future Role of SGLT-2 Inhibitors

Organised by Radcliffe supported with an unrestricted educational grant from
Boehringer Ingelheim
15:30 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic
heart failure
16:50 The real world of heart failure: putting evidence from trials and guideline
recommendations into clinical practice - Sponsored by Novartis
17:25 Hot Line - GUIDE-HF

17:55 Hot Line - EMPEROR-Preserved / EMPEROR-Pooled

18:40 Hot Line - SMART-MI- ICMs

19:00 6 years on, what have we learned from Real World use of PCSK9i ?
Sponsored by AMGEN

FRIDAY, 27 AUGUST
19:30 Changing the journey of patients with transthyretin amyloid cardiomyopathy
(ATTR-CM) - Sponsored by Pfizer
20:15 The Day in Focus - Exclusive for Members & FESC

CHANNEL
> LIVE BY TOPIC
ABSTRACT PROGRAMME & DISCUSSIONS
PRESENTATIONS > TUTORIALS
Our traditional on-site Practical Tutorials have been
20:15 Highlights from the Young in atrial fibrillation revisited to accommodate interactive learning between
technical and/or clinical experts in the field and
20:15 Stress echocardiography: key imaging test in clinical practice
delegates in a virtual classroom environment.
20:15 Emerging implications of COVID-19 in acute cardiac care You can access them through our schedule overview in
20:15 Straight from the Heart - Best cases from the Young the online programme or directly through the virtual
exhibition stand of the sponsor hosting the virtual
20:15 SARS-CoV-2 in the heart: a reason to worry ?
Tutorials: Bristol Myers Squibb and Pfizer, GE Healthcare,
20:15 COVID-19 and basic science Roche Diagnostics International and Servier.

20:15 Diabetes and kidney disease in heart failure: how should we treat the terrible
triplets ?
20:15 Highlights from the Young on cutting edge therapy for lowering lipids
> ACCESS THE RESEARCH GATEWAY
Book time to consult abstracts, clinical cases and latest
20:15 Novel insights into aortic syndromes science on demand. Interact and share with the presenters
20:15 Can we improve outcomes by targeting metabolic risk ? and your peers from all over the world.

20:15 A deep dive into mitral regurgitation

4
SATURDAY, 28 AUGUST All times in the programme are Central European Summer Time (CEST).

> LIVE ABSTRACT PRESENTATIONS & DISCUSSIONS > CHANNEL PROGRAMME

O7:15 Atrial fibrillation: risks and management Channel 1 - Advances in Science Channel 2 - Cardiovascular Channel 3 - Arrhythmias
Pharmacology and Device Therapy
O7:15 Highlights from the Young in basic science
08:00 Triage of suspected ACS patients 08:00 Great Debate : anticoagulation for 08:00 Great Debate: cryoablation as first line
stroke prevention in atrial fibrillation – treatment for atrial fibrillation. Time for
O7:15 New imaging insights into valvular heart disease 09:00 Lp(a) : From CV risk marker to the grey zone a change to increase efficacy and safety ?
therapeutic target - Sponsored by
O7:15 Frontiers in the diagnosis and management of cardiac arrest PACE-CME 09:00 Why we should not settle for 'ongoing 09:00 Transthoracic echo like you've never
angina', how some hospitals lead by seen before. - Sponsored by PHILIPS
O7:15 Novel insights in electrophysiology and wearables - Best cases from the Young 09:30 Diastolic blood pressure: should we example. - Sponsored by Abbott Healthcare
care ?
O7:15 Cardiac arrhythmias and COVID-19 09:30 Challenges of cardiovascular 09:30 Defying the odds of stroke in patients
10:30 Advances in science on big data pharmacotherapy in the elderly with atrial fibrillation : dealing with the
O7:15 Highlights from the Young in digital health 11:30 Sequential treatment strategy left atrium - Joint with the European
10:30 Cardiac remuscularization : which is Stroke Organisation (ESO)
in dyslipidemia vs earlier use of the best approach ?
O7:15 Highlights from the Young in heart failure combination therapies: decision- 10:30 Sudden cardiac death: from - prevention
making factors - Sponsored by 11:30 Roundtable discussion: NOACs to early intervention ! - Joint with the
07:15 Cardiovascular intervention : patient risk and technical features SERVIER in patients with atrial fibrillation Canadian Cardiovascular Society (CCS)
and comorbidities - Sponsored by
12:00 Risk stratification in heart disease: Boehringer Ingelheim 11:30 Key insights from guidelines, clinical
07:15 New insights into cardio-oncology
the power of molecular tools

SATURDAY, 28 AUGUST
trials and real-world evidence to help
12:00 Meet the Experts : new cardiorenal improve heart failure treatment -
O7:15 Autoimmune disorders in cardiac disease 13:00 Evolving Cardiovascular risk : Your pharmacotherapy for diabetes Sponsored by Novartis
patient's past, present and future -
O7:15 Aortic stenosis: from ‘intelligent stethoscope to TAVI' Sponsored by Bayer AG 13:00 Chronic Coronary Syndrome 12:00 Great Debate: will VT ablation improve
management in clinical practice: long-term outcome ?
challenges in prevention and
symptoms control - Sponsored by 13:00 The benefits of digital health interventions
SERVIER in cardiovascular disease - Sponsored by
WeHealthTM Digital Medicine

Channel 4 - Basic Science Channel 5 - Coronary Artery Disease Channel 6 - Heart Failure
Acute Cardiac Care
08:00 Great Debate: is single cell biology a 08:00 How to triage the patient with 08:00 Preventing sudden death in heart failure
door-opener for personalised medicine suspected NSTE-ACS
or just another playground ? 09:00 Updated ESC-HF guidelines for the
09:00 Cardiac Contractility Modulation : treatment of mitral regurgitation
09:00 Diagnostic and management challenges Device Based Interventional Heart and tricuspid regurgitation; what you
in HCM - Sponsored by Bristol Myers Failure Management - Sponsored by need to know - Sponsored by Edwards
Squibb Impulse Dynamics Lifesciences
09:30 Late Breaking Basic & Translational 09:30 Important aspects of cardiovascular 09:30 How-To manage HFpEF : state of the art
Science disease in patients with diabetes - in 2021
Joint with the European Association
10:30 Heart failure : a disease of the blood or for the Study of Diabetes (EASD) 10:30 Optimising heart failure management
blood vessels ?
10:30 Cardiac arrest and CPR 2021 : hot 11:30 Glucagon-like peptide 1 receptor
11:30 2021 EHRA Practical Guide on the use topics - Joint with the European agonists in clinical cardiology practice -
of NOACs in patients with atrial fibril- Resuscitation Council (ERC) Sponsored by Novo Nordisk A/S
lation- impact on treatment of elderly
atrial fibrillation patients ? - Sponsored 11:30 The Path to Renal Denervation: 12:00 Great Debate: vasodilators no longer
by Daiichi Sankyo Europe GmbH Newest Data and Patient Considera- have a role in the treatment of acute
tions - Sponsored by Medtronic heart failure
12:00 Will basic science solve the problem of
arrhythmias ? 12:00 Meet the Experts: difficult decisions 13:00 New Trends in Fibrinolysis - Sponsored
in management of acute coronary by Boehringer Ingelheim International
13:00 Optimising oral anticoagulation for syndromes GmbH
atrial fibrillation patients undergoing
cardiac interventions in 2021: From 13:00 Guidelines on NOACs in patients
evidence to practice - Sponsored by with atrial fibrillation : updates and
Bristol Myers Squibb and Pfizer practical insights - Sponsored by
Boehringer Ingelheim
5
SATURDAY, 28 AUGUST All times in the programme are Central European Summer Time (CEST).

> CHANNEL BY
PROGRAMME
TOPIC PROGRAMME

Channel 7 - Cardiovascular Channel 8 - Interventional Cardiology & Channel 9 - Preventive Cardiology, Channel 10 - Valvular, Myocardial, Pericardial, Channel 11 - Nursing
Imaging CV Surgery, Stroke, PAD, Aortic Disease Special Populations Pulmonary, Congenital Heart Disease and Allied Professionals
08:00 Meet the Experts : computed 08:00 Dealing with transcatheter aortic 08:00 Great Debate: metformin – still first- 08:00 Guidelines in Practice : management 08:00 Great debate: do digital health
tomography evaluation prior valve implantation (TAVI) challenges line therapy in type 2 diabetes and of atrial septal defect with pulmonary interventions work for all
to transcatheter aortic valve heart disease ? hypertension cardiovascular patients ?
implantation 09:30 The aorta and sudden cardiac death :
from tip to toe 09:30 Cardiotoxicity of cancer therapy: a 09:30 Preventing maternal sudden cardiac 09:30 Person-centred care for people with
09:30 New frontiers in cardiovascular clinical update death implantable cardioverter defibrillators
computed tomography 10:30 Embolic stroke of unknown source: not
so cryptic after all 10:30 Preventing atherosclerotic vascular 10:30 Drug treatment of inherited 10:30 Advanced nurse roles in
10:30 Nuts and bolts of using cardiac CT in disease throughout life: the earlier cardiomyopathies cardiovascular care : what does the
preventive cardiology 12:00 Great Debate: controversies in left the better - Joint with the European future look like ?
main revascularisation – to stent or to Atherosclerosis Society (EAS) 12:00 Meet the Experts: genetic variants
12:00 Guidelines in Practice : working up operate ? in cardiovascular disease – what 12:00 Understanding spontaneous coronary
acute chest pain – imaging in a patient 12:00 Meet the Experts: fuel up! – targeting clinicians need to know artery dissection
with a nondiagnostic ECG cardiac energy metabolism in type 2
diabetes and heart failure…

SATURDAY, 28 AUGUST
Channel 12 - Awards Channel 13 - Core Cardiology Channel 14 - Cardiology Toolbox Channel 15 - International Joint Sessions
and Named Lectures
08:00 Young Investigator Awards Session in 08:00 Essentials in Imaging – 2 : When and 08:00 How to interpret 24-hour and smart 08:00 Diabetes and cardiovascular disease :
Clinical Cardiology how to use cardiac MR, CT and FoCUS watch ECGs facing the big challenge ahead - Joint
with the Mexican Society of Cardio-
09:30 ESC Rene Laennec Lecture on Clinical 09:30 Essentials in Valvular Heart Disease – 09:30 Workup of syncope: an algorithmic logy (MSC)
Cardiology and Andreas Gruntzig 2: Challenging Clinical Scenarios approach
Lecture on Interventional Cardiology 09:30 Adult congenital heart disease :
10:30 Essentials in Prevention – 2 : Drug 10:30 Lipid lowering beyond LDL-cholesterol current situation and future issues -
10:30 Young Investigator Awards Session in Treatment in Primary Prevention and statins Joint with the Japanese Circulation
Thrombosis Society (JCS)
12:00 Essentials in the Cardiology Clinic - 2 : 12:00 Statistics and interpretation of clinical
12:00 Best Clinical Cases Awards Session - Pulmonary Hypertension, Congenital trials 10:30 Primary prevention in the Asia-Pacific
Best cases from the Young Heart Disease and Pregnancy region - Joint with the Asian Pacific
Society of Cardiology (APSC)
12:00 Novel approaches to the treatment of
heart failure : a summary - Joint with
the Saudi Heart Association (SHA)

6
SATURDAY, 28 AUGUST All times in the programme are Central European Summer Time (CEST).

> PRIME
CHANNEL
TIME
BYPROGRAMME
TOPIC PROGRAMME

14:00 Hot Line - MASTER DAPT

14:30 Hot Line - ENVISAGE-TAVI AF

15:00 New therapies for patients following a worsening HF event - Sponsored by

Bayer AG
15:30 2021 ESC/EACTS Guidelines for the management of valvular heart disease

16:50 SGLT2 Inhibitor HFpEF Data: From Context to Clinical Pearls

Organised by Medscape supported with an unrestricted educational grant
from Boehringer Ingelheim
17:25 Hot Line - FIGARO-DKD / FIDELITY Analysis

18:10 Hot Line - APAF-CRT

18:40 Hot Line - DECAAF II

19:00 Add on to take back control: Combining lipid lowering therapies for the ma-

SATURDAY, 28 AUGUST
nagement of high and very high risk patients - Sponsored by Daiichi Sankyo
Europe
19:30 Venous thromboembolism management in patients with cancer: From trials to
clinical practice - Sponsored by Bristol Myers Squibb and Pfizer
20:15 The Day in Focus - Excusive for Members & FESC

>
> CHANNEL BY TOPIC
LIVE ABSTRACT PROGRAMME & DISCUSSIONS
PRESENTATIONS > TUTORIALS
Our traditional on-site Practical Tutorials have been
20:15 Atrial fibrillation: the role of risk markers
revisited to accommodate interactive learning between
20:15 Transcriptomics and metabolomics to decipher cardiovascular disease technical and/or clinical experts in the field and
delegates in a virtual classroom environment.
20:15 Cardiac computed tomography : from registries to new applications in corona-
ry artery disease and beyond
You can access them through our schedule overview in
20:15 Highlights from the Young in coronary artery disease the online programme or directly through the virtual
exhibition stand of the sponsor hosting the virtual
20:15 Best clinical cases in acute cardiac care - Best cases from the Young Tutorials: Bristol Myers Squibb and Pfizer, GE Healthcare,
Roche Diagnostics International and Servier.
20:15 COVID-19 insights from non-invasive imaging: what have we learned one year
later ?
20:15 Risk factors for outcome in COVID-19
> ACCESS THE RESEARCH GATEWAY
20:15 COVID and digital health
Book time to consult abstracts, clinical cases and latest
20:15 Acute heart failure: think long-term outcome ! science on demand. Interact and share with the presenters
and your peers from all over the world.
20:15 New Insights into cardiovascular surgery

20:15 Diabetic metabolism and cardiovascular risk

20:15 Frontiers in prognostic research in hypertrophic cardiomyopathy

7
SUNDAY, 29 AUGUST All times in the programme are Central European Summer Time (CEST).

> LIVE ABSTRACT PRESENTATIONS & DISCUSSIONS > CHANNEL PROGRAMME

07:15 Syncope, bradycardia and pacemakers : details matter Channel 1 - COVID-19 Channel 2 - Late-Breaking Science Channel 3 - Arrhythmias
and Device Therapy
07:15 Advances in atherosclerosis research
08:00 Late Breaking Trials - COVID-19 08:00 Late Breaking Trials in Hypertension 08:00 Atrial arrhythmias and
anticoagulation: challenging clinical
07:15 Hot topics in cardiac magnetic resonance 09:30 Preventing and managing COVID-19 : 09:30 Patient selection for Temporary scenarios
where are we ? Mechanical Circulatory Support :
07:15 Chronic coronary syndromes: pathophysiology, treatment, and prognosis who benefits the most ? - Sponsored 09:30 A new treatment option in HFrEF :
10:30 Enthusiasm vs. evidence for COVID-19 by ABIOMED How can we incorporate SGLT2
07:15 Nightmare at the cath lab - Best cases from the Young pharmacotherapies : inhibitors into clinical practice ? -
what do we know and what have we 09:30 Global burden of cardiovascular Sponsored by the Boehringer
07:15 COVID-19 and acute coronary syndromes learnt ? - Joint with the International disease in women; 20/20 vision Ingelheim and Eli Lilly and
Society of Cardiovascular for 2030 : report of The Lancet Company Alliance
07:15 e-Cardiology/digital health Pharmacotherapy (ISCP) commission
09:30 Treatment of asymptomatic patients
11:30 Patient's phenotype at the center of 10:30 Registries on Valve with arrhythmic substrates : do
07:15 Cutting-edge clinical investigations in heart failure our clinical decisions in heart failure :
11:30 Empagliflozin across the spectrum benefits outweigh side effects ?
mission (im)possible ? - Sponsored by
07:15 Highlights from the Young in Intervention SERVIER of ejection fraction in HF aggregate 10:30 Cardiac device infections : risks and
findings from the EMPEROR prevention
07:15 Burning questions for cardiovascular nursing and allied professions 12:00 Late-Breaking Science on Special programme - Sponsored by Charité
Populations Friends & Sponsors Trust. 11:30 New options for LDL-C management in

SUNDAY, 29 AUGUST
07:15 Predicting outcomes in patients with infective endocarditis ASCVD - Sponsored by Novartis
13:00 What's next for your patients following 12:00 Highlights from NEJM - Joint with
a worsening HF event ? - Sponsored NEJM 12:00 Meet the Experts: risk calculators to
by Bayer AG predict sudden cardiac death
13:00 Single-pill combinations (SPCs) first in cardiomyopathies. A blessing
line in ESC/ESH 2018 guidelines for in disguise ?
hypertensive patients : where do we
stand 3 years later ? - Sponsored by 13:00 Screening for atrial fibrillation: From risk
Servier prediction to detection and diagnosis to
clinical outcomes - Sponsored by Bristol
Myers Squibb and Pfizer

Channel 4 - Basic Science Channel 5 - Coronary Artery Disease Channel 6 - Heart Failure
Acute Cardiac Care
08:00 Scientists of Tomorrow meet the 08:00 Saving the ventricle in acute 08:00 Guidelines in Practice: management of
scientists of today myocardial infarction with cardiogenic a multimorbid patient with HFrEF
shock (AMICS): ventricular unloading
09:30 The Clock is Ticking: The Imminent debunked 09:30 Transcatheter options for the
Need to Re-evaluate Standard of Care management of HF patients with
in the 90-Day High-Risk Post-AMI 09:30 Spontaneous coronary artery dissec- MR or TR - the new ESC-HF & VHD
Period - Sponsored by CSL Behring tion in STEMI guidelines - Sponsored by Edwards
Lifesciences
9:30 Genetic variants and transcriptional 10:30 Trial Updates in ACS & PCI
regulators in cardiovascular disease 10:30 Solutions for typical clinical problems
11:30 Why ZEUS ? Interleukin-6 as the next to optimise drug therapy for heart
10:30 CRISPR/Cas9 gene editing for heart potential frontier in anti-inflammatory failure
disease: ready for prime time ? management of atherosclerotic
cardiovascular disease - Sponsored by 11:30 Tackling residual risk beyond LDL-c
11:30 Implantable cardiac devices: Where do Novo Nordisk A/S therapy : The emerging role of EPA &
we stand ? - Sponsored by Medtronic triglycerides - Sponsored by PACE-
12:00 Meet the Experts: cardiovascular CME
12:00 HFpEF : different mechanistic phe- catastrophes in critical care
notypes require distinct therapeutic – advanced therapies in acute 12:00 Hot off the press: latest updates on
strategies myocarditis and electrical storm new therapeutic approaches to HFrEF
13:00 Guidelines in atrial fibrillation: 13:00 Getting to the heart of clinical inertia 13:00 TAVI Update: Latest evidence leads
application in clinical cases - in the management of RAASi-related to growing confidence in patient
Sponsored by Boehringer Ingelheim hyperkalaemia - Organised by treatment - Sponsored by Medtronic
CHANGE IME with an unrestricted
educational grant from AstraZeneca

8
SUNDAY, 29 AUGUST All times in the programme are Central European Summer Time (CEST).

> CHANNEL BY
PROGRAMME
TOPIC PROGRAMME

Channel 7 - Cardiovascular Imaging Channel 8 - Interventional Cardiology & Channel 9 - Preventive Cardiology, Channel 10 - Valvular, Myocardial, Pericardial, Channel 11 - Journal Sessions
CV Surgery, Stroke, PAD, Aortic Disease Special Populations Pulmonary, Congenital Heart Disease
08:00 Meet the Experts : cardiac magnetic 08:00 Great Debate: antithrombotic 08:00 How should we treat pulmonary 08:00 The EHJ’s Year in Cardiovascular
resonance perfusion imaging therapeutic dilemmas in PAD – 08:00 Guidelines in Practice : sports arterial hypertension: same old news Medicine 2020 : epidemiology and
dual antiplatelet or dual-pathway participation of athletes with coronary or new therapies on the horizon ? prevention, ischaemic heart disease,
09:30 Imaging heart failure with preserved antithrombotic therapy ? disease – finding the right balance acute coronary syndromes
ejection fraction 09:30 TAVI in bicuspid aortic valves: a
09:30 Preventing recurrent stroke : drugs 09:30 Obstructive sleep apnoea (OSA : what challenge 09:30 The EHJ’s Year in Cardiovascular
10:30 Late Breaking Science in Imaging and devices the cardiologist must know - Joint Medicine 2020 : heart failure, valvular
with the European Respiratory 10:30 Tricuspid valve regurgitation : heart disease, imaging
12:00 When echocardiography is not enough : 10:30 Genetic aortic diseases: a deep treatments for the not so forgotten
multimodality imaging to the rescue Society (ERS)
dive on clinical presentation and valve 10:30 Best of Cardiovascular Research
management 10:30 Late Breaking Science in Prevention
12:00 Sudden cardiac death in adult 12:00 The Best of the ESC Journal Family :
12:00 Great Debate: when less is more – 12:00 Meet the Experts : the How-To of congenital heart disease (ACHD) top cited papers in 2021
options to reduce the risk of bleeding exercise prescription in cardiovascular
after PCI disease

SUNDAY, 29 AUGUST
Channel 12 - Awards and Named Lectures Channel 13 - Core Cardiology Channel 14 - Cardiology Toolbox Channel 15 - International Joint Sessions

08:00 Young Investigator Awards Session 08:00 Essentials in Prevention – 3 : 08:00 Spiroergometry in clinical practice 08:00 Therapeutic interventions and risk
in Coronary Pathophysiology and Secondary Prevention and Sports of sudden cardiac death in structural
Microcirculation Cardiology 09:30 24-hour ambulatory blood pressure heart disease - Joint with the
recordings in clinical practice Brazilian Society of Cardiology (BSC)
09:30 ESC Paul Hugenholtz Lecture for 09:30 Essentials in Coronary Artery Disease
Innovation and William Harvey Lecture - 1 : Contemporary Management 10:30 Diagnostic pearls of right heart 09:30 Prediction of sudden cardiac death :
on Basic Science of Acute and Chronic Coronary catheterisation genetic testing, ECG, and imaging -
Syndromes 12:00 Management of secondary Joint with the Japanese Circulation
10:30 Young Investigator Awards Session in Society (JCS)
Basic Science 10:30 Essentials in Arrhythmias – 1 : Advice hypertension
for the Management of Malignant 10:30 Global perspectives on structural
12:00 Young Investigator Awards Session in Arrhythmias heart disease - Joint with the Great
Sudden Cardiac Death Wall International Congress of Cardio-
12:00 Essentials in Heart Failure – 1 : logy (GW-ICC)
Definition, Prevention, Diagnosis
12:00 Management of heart failure in
special populations - Joint with the
Cardiological Society of India (CSI)

9
SUNDAY, 29 AUGUST All times in the programme are Central European Summer Time (CEST).

> PRIME
CHANNEL
TIME
BYPROGRAMME
TOPIC PROGRAMME

14:00 Hot Line - TOMAHAWK

14:30 Hot Line - RIPCORD 2

15:00 The new decade in ASCVD - Sponsored by Novartis

15:30 2021 ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy

16:50 Exploring the cardiorenal benefits of MR antagonism in CKD and T2D -

Sponsored by Bayer AG
17:25 Hot Line - ACST-2

17:55 Hot Line - LOOP Study

18:25 Hot Line - SSaSS

19:00 SGLT2 inhibitors and heart failure in the cardiorenal spectrum - Organised
by CHANGE IME supported by an unrestricted educational grant from
AstraZeneca

SUNDAY, 29 AUGUST
19:30 SGLT2 inhibitors and heart failure in the cardiorenal spectrum - Organised
by CHANGE IME supported by an unrestricted educational grant from
AstraZeneca
20:15 The Day in Focus - Exclusive for Members & FESC

>
> CHANNEL BY TOPIC
LIVE ABSTRACT PROGRAMME & DISCUSSIONS
PRESENTATIONS > TUTORIALS
Our traditional on-site Practical Tutorials have been
20:15 Inherited diseases and ventricular arrhythmias revisited to accommodate interactive learning between
20:15 Novel insights into arrhythmia mechanisms technical and/or clinical experts in the field and
delegates in a virtual classroom environment.
20:15 Acute coronary syndromes: diagnosis, treatment, outcomes
You can access them through our schedule overview in
20:15 COVID-19 and percutaneous intervention the online programme or directly through the virtual
exhibition stand of the sponsor hosting the virtual
20:15 COVID-19 and cardiovascular pharmacotherapy
Tutorials: Bristol Myers Squibb and Pfizer, GE Healthcare,
20:15 Public health and health economics Roche Diagnostics International and Servier.

20:15 New frontiers in devices and transplantation

20:15 Novel insight into thromboembolic stroke and transient ischemic attack > ACCESS THE RESEARCH GATEWAY
20:15 Highlights from the Young in risk factors revisited Book time to consult abstracts, clinical cases and latest
science on demand. Interact and share with the presenters
20:15 Advances in congenital heart disease: learning from registries and advanced
imaging and your peers from all over the world.

10
MONDAY, 30 AUGUST All times in the programme are Central European Summer Time (CEST).

> LIVE ABSTRACT PRESENTATIONS & DISCUSSIONS > CHANNEL PROGRAMME

07:15 Clinical questions: management of patients with atrial fibrillation Channel 1 - Digital Health, Public Health, Channel 2 - Hypertension Channel 3 - Arrhythmias
Health Economics and Device Therapy
07:15 Novel insights into metabolic strategies to treat cardiovascular disease
08:00 Practical advice for digitally enabled 08:00 Meet the Experts : invasive treatment
patient follow-up : stay connected ! of hypertension 08:00 Meet the Experts : sudden cardiac
07:15 I want to learn more about the most recent research results from
death in the patient with an
multimodality imaging 09:30 Modern Glycaemic Management to 09:30 Precision medicine in the digital world : apparently normal heart
reduce CV risk in Diabetes - from data analytics to augmented
07:15 Acute coronary syndromes pathophysiology and mechanisms : what's new ?
Sponsored by Abbott Diabetes Care reality - Sponsored by Siemens 09:30 Managing recurring ICD shocks for
Healthineers ventricular tachyarrhythmias
07:15 Novel therapies for heart failure in the early pipeline 9:30 Social media for the cardiologist
9:30 Meet the Experts: hypertension, atrial 10:30 Tips and tricks in cardiac
07:15 Best of peripheral vascular and cerebrovascular disease 10:30 Death is analogue : let's go digital fibrillation and dementia resynchronisation therapy -
11:30 Cardiac biomarkers are here to stay - 10:30 Hypertension and sudden cardiac 11:30 Changing care delivery for coronary
07:15 Rehabilitation and sports cardiology Sponsored by Roche death - Joint with the European artery disease - Sponsored by GE
Diagnostics International Society of Hypertension (ESH) Healthcare
07:15 Pulmonary arterial hypertension : risk stratification guides for new
treatments and informed outcomes 12:00 Great Debate : artificial intelligence 11:30 Iron deficiency as a therapeutic target 12:00 New methods for atrial
in cardiology – a marriage made in in heart failure - new evidence, new fibrillation ablation: improving efficacy
heaven or hell ? guidelines - Sponsored by Charité and safety
13:00 A STEP forward : Weight loss and Friends & Sponsors Trust

MONDAY, 30 AUGUST
13:00 Potassium binding in heart failure
improved cardiovascular risk factors - 12:00 Meet the Experts: how to approach management: Enabling guideline-
Sponsored by Novo Nordisk A/S the combination of hypertension and recommended RAASi therapy -
atrial fibrillation Sponsored by PACE-CME
13:00 The big picture of chronic coronary
syndromes - Looking for optimal
patient outcome - Sponsored by
Menarini Group

Channel 4 - Basic Science Channel 5 - Coronary Artery Disease Channel 6 - Heart Failure
Acute Cardiac Care
08:00 RNA Therapeutics : from vaccination 08:00 Great Debate : rise of the machines ? – 08:00 Everything you need to know about
to regenerative medicine human vs. artificial intelligence for ECG SGLT2 inhibitors in heart failure
interpretation
09:30 Single cell biology and analysis : how 09:30 Meet the Experts : difficult decisions
to make sense of single cell data 09:30 Nonobstructive coronary artery in advanced heart failure
disease : why bother ?
10:30 What´s wrong with current models of 10:30 Advances in science in heart failure:
cardiovascular disease ? 10:30 You only live twice : key resuscitation what does the new
controversies in 2021 decade hold for ventricular
11:30 Telehealth and Remote Patient assist devices ?
Monitoring in Cardiology : from 11:30 New treatment option for acute
temporary adoption during pandemic Pulmonary Embolism patients : Percu- 11:30 Does HCM have the same pathways to
to standard of care ? - Sponsored by taneous pulmonary embolectomy with Heart Failure? Sponsored by Bristol
Siemens Healthineers a large-bore catheter system - First Myers Squibb
European Experience - Sponsored by
12:00 What does science teach us about life Inari Medical Europe GmbH 12:00 Valve interventions for heart failure:
with genetic heart disease ? state of the art
12:00 Guidelines in Practice : acute
13:00 Cardiovascular risk assessment and pulmonary embolism 13:00 The Future of TAVI : How are the
prevention: Where do we stand now ? - new 2021 ESC VHD guidelines
Sponsored by Abbott 13:00 The Global problem of Heart failure : changing management and treatment
options when drug therapy is not of patients with aortic stenosis -
enough ? - Sponsored by Abbott Sponsored by Edwards Lifesciences

11
MONDAY, 30 AUGUST All times in the programme are Central European Summer Time (CEST).

> CHANNEL BY
PROGRAMME
TOPIC PROGRAMME

Channel 7 - Cardiovascular Imaging Channel 8 - Interventional Cardiology & Channel 9 - Preventive Cardiology, Channel 10 - Valvular, Myocardial, Pericardial, Channel 11 - Journals Joint Sessions
CV Surgery, Stroke, PAD, Aortic Disease Special Populations Pulmonary, Congenital Heart Disease
08:00 Great Debate: is left ventricular 08:00 Antithrombotic therapy after TAVI 08:00 Meet the Experts: intervention in 08:00 Circulation: the full spectrum - Joint
dyssynchrony in imaging relevant for 08:00 Meet the Experts : endurance training primary mitral regurgitation with Circulation
the selection of patients for cardiac 09:30 Saving lives: STEMI and cardiogenic – is it all good news ?
resynchronization therapy ? shock 09:30 NOACs in adult congenital heart 09:30 The Lancet – Focus on Hypertension
09:30 Management of risk factors in the disease: show me the evidence ! - 2021 - Joint with The Lancet
09:30 Imaging for risk stratification of native 10:30 Evolving frontiers for coronary artery elderly - Joint with the Argentine Joint with the International Society
valvular regurgitation disease Society of Cardiology (ASC) for Adult Congenital Heart Disease 10:30 JACC Global burden of cardiovascular
(ISACHD) disease: the changing dynamics of
10:30 Late Breaking Science in Artificial 12:00 When coronary angiography is not 10:30 Cardiac biomarkers for atherosclerotic CVD - Joint with JACC
Intelligence & Digital Health enough: morphology or physiology ? cardiovascular disease risk prediction 10:30 Fontan-associated liver disease - Joint
with the Association for European 12:00 Highlights of JAMA Cardiology
12:00 Great Debate: post-ISCHEMIA and 12:00 Preventing sudden cardiac death in Paediatric Cardiology (AEPC) Publications 2020-2021 - Joint with
SCOT-HEART – anatomy is all we need young athletes JAMA Cardiology
for risk stratification and treatment 12:00 Managing multivalve disease: decision
dilemmas

MONDAY, 30 AUGUST
Channel 13 - Core Cardiology Channel 14 - Cardiology Toolbox Channel 15 - International Joint Sessions

08:00 Essentials in Coronary Artery Disease 08:00 Extracorporeal cardiopulmonary 08:00 Epidemiology and investigation of
– 2 : Personalised Decisions in Difficult resuscitation (ECPR) in action : sudden cardiac death in the young
Scenarios lessons from the experts - Joint with the Cardiac Society of
Australia and New Zealand (CSANZ)
09:30 Essentials in Arrhythmias – 2 : A 09:30 Chest X-ray and lung ultrasound for
Structured Approach to Managing the cardiologist 09:30 Sudden cardiac death in Asia - Joint
Atrial Fibrillation with the Korean Society of Cardiology
10:30 Coronary complications and how to (KSC)
10:30 Essentials in Heart Failure – 2 : fix them
Therapeutic Targets 10:30 Myocardial adaptation and
12:00 LDL lowering – dealing with difficult maladaptation in failing heart - Joint
situations with the Japanese Circulation
Society (JCS) - Young Community
12:00 Primary prevention guidelines : a
comparison between the Chinese
Society of Cardiology and the
European Society of Cardiology -
Joint with the Chinese Society of
Cardiology (CSC)

12
MONDAY, 30 AUGUST All times in the programme are Central European Summer Time (CEST).

> PRIME
CHANNEL
TIME
BYPROGRAMME
TOPIC PROGRAMME

14:00 Hot Line - IAMI

14:30 Hot Line - PRONOUNCE

15:00 Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with

Atrial Fibrillation : Results from ENVISAGE-TAVI AF trial. - Sponsored by
Daiichi Sankyo Europe GmbH
15:30 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

16:50 Hypertension-How and Why Should We Use Single-Pill Combinations in

Practice - Organised by MedscapeLive – Supported by an unrestricted
educational grant from Sanofi
17:25 Hot Line - STEP Study

17:55 Hot Line - Amulet IDE

18:25 Hot Line - STOPDAPT-2 ACS

19:00 LDL-C management in ACS: Time to Act - Sponsored by Amgen

MONDAY, 30 AUGUST
19:30 Dyslipidemia Challenge - Closing the Gap Between Guidelines and Clinical
Practice - Organised by Medscape Live with an unrestricted educational
grant from Sanofi
20:15 The Day in Focus - Exclusive for Members & FESC

> LIVE ABSTRACT PRESENTATIONS & DISCUSSIONS > TUTORIALS

Our traditional on-site Practical Tutorials have been
20:15 Inherited diseases and ventricular arrhythmias revisited to accommodate interactive learning between

20:15 Novel insights into arrhythmia mechanisms technical and/or xclinical experts in the field and
delegates in a virtual classroom environment.
20:15 Acute coronary syndromes: diagnosis, treatment, outcomes
You can access them through our schedule overview in
20:15 COVID-19 and percutaneous intervention the online programme or directly through the virtual
exhibition stand of the sponsor hosting the virtual
20:15 COVID-19 and cardiovascular pharmacotherapy
Tutorials: Bristol Myers Squibb and Pfizer, GE Healthcare,
20:15 Public health and health economics Roche Diagnostics International and Servier.

20:15 New frontiers in devices and transplantation

20:15 Novel insight into thromboembolic stroke and transient ischemic attack > ACCESS THE RESEARCH GATEWAY
20:15 Highlights from the Young in risk factors revisited Book time to consult abstracts, clinical cases and latest
science on demand. Interact and share with the presenters
20:15 Advances in congenital heart disease: learning from registries and advanced
and your peers from all over the world.
imaging

13
 ESC
CONGRESS
2021
THE DIGITAL EXPERIENCE
27 - 30 August

www.escardio.org/ESC2021
#ESCCongress